- Home
- RGR vs BBOT Comparison
RGR vs BBOT Comparison
Compare RGR & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGR | BBOT |
|---|---|---|
| Founded | 1949 | 2016 |
| Country | United States | United States |
| Employees | N/A | 106 |
| Industry | Ordnance And Accessories | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.8M | 605.6M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | RGR | BBOT |
|---|---|---|
| Price | $38.57 | $8.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $43.00 | $24.00 |
| AVG Volume (30 Days) | 133.2K | ★ 510.7K |
| Earning Date | 05-06-2026 | 05-26-2026 |
| Dividend Yield | ★ 1.07% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $546,057,000.00 | N/A |
| Revenue This Year | $2.38 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3,856.00 | ★ N/A |
| Revenue Growth | ★ 1.94 | N/A |
| 52 Week Low | $28.33 | $7.00 |
| 52 Week High | $48.21 | $14.87 |
Technical Indicators
Market Signals| Indicator | RGR | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 50.68 | 52.92 |
| Support Level | $38.60 | $8.02 |
| Resistance Level | $38.89 | $9.50 |
| Average True Range (ATR) | 0.98 | 0.58 |
| MACD | 0.07 | 0.15 |
| Stochastic Oscillator | 36.12 | 47.47 |
Price Performance
Historical ComparisonAbout RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States, and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.